Clark David J 4
4 · Aldeyra Therapeutics, Inc. · Filed Mar 7, 2019
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Common Stock
2019-03-05+3,503→ 11,512 total - Award
Employee Stock Option (Right to Buy)
2019-03-05+250,000→ 250,000 totalExercise: $8.05Exp: 2029-03-04→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
- [F2]Includes 3,235 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2018.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019.